longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

agilon health

AGL

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -5.84, within the reasonable range, cheaper than 35.43% of the time in the past 5 years, and the industry ranks 44/74, the industry Median --.

-5.84xP/E
$80.73Stock price
$-13.83Earnings per share
-5.84xP/E
Stock price$80.73Earnings per share$-13.83

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-9.40x
Typical range
-78.16x–-3.47x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
GHUSGuardant Health
-52.46x2.92%$23.79B
HIMSUSHims & Hers Health
-48.33x209.86%$6.86B
RDNTUSRadnet
-263.83x128.00%$5.57B
WGSUSGeneDx
-24.79x359.59%$2.64B
NEOUSNeogenomics
-47.87x64.73%$2.48B
AGLUSagilon health
-5.84x92.48%$1.36B
INNVUSInnovage
-484.06x2,301.70%$1.23B
OPKUSOpko Health
-16.79x25.44%$1.22B
CSTLUSCastle Biosciences
-56.35x52.61%$1.09B
LMRIUSLumexa Imaging
-35.38x145.51%$980.93M
FLGTUSFulgent Genetics
-7.24x42.64%$610.84M
GMRSUSGMR Solutions
-7.90x91.45%$597.48M
PREUSPrenetics Global
-8.38x16.63%$393.79M
AONCUSAmerican Oncology Network
----$371.06M
BDSXUSBiodesix
-11.06x42.77%$307.04M
GAMGUSGlobal Asset Management Group, Inc.
-350.92x--$198.07M
NAKAUSNakamoto
-0.43x102.50%$178.77M
AIRSUSAirSculpt Tech
-12.04x33.33%$141.31M
CORBFUSGlobal Cord Blood Corporation
----$127.35M
PARKUSPark Dental Partners
-26.78x--$94.68M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.